Scancell Holdings PLC (SCLP)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

9.50p

Buy

10.25p

arrow-up0.475p (+5.05%)

Prices updated at 08 May 2024, 15:15 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Scancell Holdings PLC is a biopharmaceutical company focused on the cancer therapeutics market. The company's principal activity consists of the discovery and development of monoclonal antibodies and vaccines for the treatment of cancer.
FTSE All-Share
arrow-up0.06%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
9.40
triangle-d
arrow-up
0.48 (+5.05%)
triangle-d
Today open
9.88
triangle-d
arrow-up
0.00 (+0.00%)
triangle-d
Today, 15:15:02 BST
9.88
triangle-d
10.25p - 9.22p
18.29p - 7.59p
-
87.32m
-
30,000
762,868
-
604,214.75
1.36
819.22m
GB00B63D3314
-0.01
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.